11-5225635-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM1BP4
The NM_000518.5(HBB):c.407C>T(p.Ala136Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,742 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A136D) has been classified as Uncertain significance.
Frequency
Consequence
NM_000518.5 missense
Scores
Clinical Significance
Conservation
Publications
- dominant beta-thalassemiaInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
- hemoglobin M diseaseInheritance: AD Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen
- beta thalassemiaInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
- beta-thalassemia HBB/LCRBInheritance: AR, SD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
- sickle cell disease and related diseasesInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- erythrocytosis, familial, 6Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Heinz body anemiaInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- sickle cell diseaseInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- hereditary persistence of fetal hemoglobin-beta-thalassemia syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- beta-thalassemia intermediaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- beta-thalassemia majorInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- delta-beta-thalassemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hemoglobin C diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hemoglobin C-beta-thalassemia syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hemoglobin E diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hemoglobin E-beta-thalassemia syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary persistence of fetal hemoglobin-sickle cell disease syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- sickle cell-beta-thalassemia disease syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- sickle cell-hemoglobin c disease syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- sickle cell-hemoglobin d disease syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- sickle cell-hemoglobin E disease syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD2 exomes  AF:  0.0000159  AC: 4AN: 251362 AF XY:  0.0000221   show subpopulations 
GnomAD4 exome  AF:  0.00000479  AC: 7AN: 1461742Hom.:  0  Cov.: 31 AF XY:  0.00000550  AC XY: 4AN XY: 727204 show subpopulations 
Age Distribution
GnomAD4 genome  
ClinVar
Submissions by phenotype
not specified    Uncertain:1 
Variant summary: HBB c.407C>T (p.Ala136Val) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251362 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.407C>T has been reported in the literature in at least one compound heterozygous individual affected with Hemoglobinopathy (e.g., Godbole_2018). These data do not allow any conclusion about variant significance. At least one publication reports experimental evidence evaluating an impact on protein function, finding that the variant results in a mildly decreased oxygen affinity (e.g., Zubriggen_2009). The following publications have been ascertained in the context of this evaluation (PMID: 29651865, 29365076, 19958196). No submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. Additionally, other missense variants have been reported in the literature in individuals affected with hemolytic anemia (c.406G>C (p.Ala136Pro) also known as Hb Altdorf) or silent hemoglobinopathies (c.407C>A (p.Ala136Asp), also known as Hb Beckman), and these other missense variants were found to be unstable and result in changes in oxygen affinity (PMIDs: 8450301, 1261680, 19453576, 26209877; Yucel_2013, no PMID)). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at